Cash & equivalents decreased 24.8%
Cash & equivalents changed -24.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -24.8% from the comparable as-filed period.
Net income changed +47.7% from the comparable as-filed period.
Stock-based compensation changed -26.1% from the comparable as-filed period.
Debt changed -6.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed -6.2% from the comparable as-filed period.
Inventory changed -7.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -5.5% from the comparable as-filed period.
Gross margin changed -58 basis points from the comparable as-filed period.
Operating margin changed -5 basis points from the comparable as-filed period.
Research & development changed +4.2% from the comparable as-filed period.
Revenue changed -4.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.